Stock Market Returns and Clinical Trial Results of Investigational Compounds: An Event Study Analysis of Large Biopharmaceutical Companies
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference47 articles.
1. Diagnosing the decline in pharmaceutical R&D efficiency;JW nnell;Nat Rev Drug Discov,2012
2. Assessing the impact of protocol design changes on clinical trial performance;KA Getz;Am J Ther,2008
3. Lessons from 60 years of pharmaceutical innovation;B Munos;Nat Rev Drug Discov,2009
4. The productivity crisis in pharmaceutical R&D;F Pammolli;Nat Rev Drug Discov,2011
5. Trends in risks associated with new drug development: success rates for investigational drugs;JA DiMasi;Clin Pharmacol Ther,2010
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Double-Blind Trial Platform Based on Distributed Ledger Technology;Electronics;2023-12-28
2. New drugs and stock market: a machine learning framework for predicting pharma market reaction to clinical trial announcements;Scientific Reports;2023-08-07
3. COVID-19 Vaccines, Healthcare Policies and Stock Markets: Are There Winners and Losers?;Risk Management and Healthcare Policy;2023-05
4. A Blockchain-Based Double-Blind Trial Platform;2023 9th International Conference on Applied System Innovation (ICASI);2023-04-21
5. Assessment of Spin in the Abstracts of Systematic Reviews and Meta-analyses on Platelet-Rich Plasma Treatment in Orthopaedics: A Cross-sectional Analysis;Orthopaedic Journal of Sports Medicine;2023-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3